(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Methes Energies International Ltd, Nova Lifestyle, and NanoString Technologies.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Methes Energies International Ltd (MEIL) | 0.05 | 50.28% | 2023-11-22 01:42:05 |
| 2 | Nova Lifestyle (NVFY) | 2.60 | 33.33% | 2023-11-22 11:10:05 |
| 3 | NanoString Technologies (NSTG) | 0.55 | 9.35% | 2023-11-22 10:17:06 |
| 4 | American Public Education (APEI) | 6.23 | 8.15% | 2023-11-22 12:10:45 |
| 5 | MicroVision (MVIS) | 2.43 | 7.05% | 2023-11-22 12:13:51 |
| 6 | NeuroMetrix (NURO) | 4.02 | 6.83% | 2023-11-22 12:50:53 |
| 7 | Mercer International (MERC) | 10.03 | 6.82% | 2023-11-22 02:23:06 |
| 8 | AMC (AMC) | 7.09 | 6.69% | 2023-11-22 12:18:19 |
| 9 | Baidu (BIDU) | 120.28 | 6.05% | 2023-11-22 12:11:00 |
| 10 | ImmunoGen (IMGN) | 16.07 | 5.65% | 2023-11-22 12:13:06 |
The three biggest losers today are National American University Holdings, Remark Holdings, and Lightbridge Corporation.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | National American University Holdings (NAUH) | 0.02 | -14.47% | 2023-11-22 07:14:05 |
| 2 | Remark Holdings (MARK) | 0.49 | -13.93% | 2023-11-21 23:46:06 |
| 3 | Lightbridge Corporation (LTBR) | 3.50 | -10.49% | 2023-11-21 23:07:05 |
| 4 | MediciNova (MNOV) | 1.86 | -9.71% | 2023-11-22 04:44:05 |
| 5 | Nektar Therapeutics (NKTR) | 0.47 | -9.62% | 2023-11-22 09:09:06 |
| 6 | LivePerson (LPSN) | 2.88 | -9.43% | 2023-11-21 22:42:06 |
| 7 | Neptune Wellness Solutions (NEPT) | 0.77 | -9.41% | 2023-11-22 07:48:06 |
| 8 | Liberty Global plc (LBTYB) | 15.74 | -7.9% | 2023-11-21 19:15:05 |
| 9 | Virgin Galactic (SPCE) | 1.97 | -7.75% | 2023-11-22 13:00:51 |
| 10 | Lipocine (LPCN) | 2.51 | -6.69% | 2023-11-21 22:23:06 |
Winners today
1. Methes Energies International Ltd (MEIL) – 50.28%
Methes Energies International Ltd., a renewable energy company, produces and sells biodiesel fuel and biodiesel processing equipment in the United States and Canada. It offers Denami biodiesel processors. The company also produces glycerin and offer services related to the production of biodiesel, as well as purchases and sells feedstock. It sells its products and services to a network of biodiesel fuel producers. The company was founded in 2004 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Methes Energies International Ltd jumping 50.28% to $0.05 on Thursday while NASDAQ rose 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Methes Energies International Ltd has a trailing twelve months EPS of $-0.98.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.54%.
Volume
Today’s last reported volume for Methes Energies International Ltd is 400 which is 98.97% below its average volume of 38982.
More news about Methes Energies International Ltd.
2. Nova Lifestyle (NVFY) – 33.33%
Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living rooms, dining rooms, bedrooms, and home offices. Its products include sofas, chairs, dining tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinics, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.
NASDAQ ended the session with Nova Lifestyle jumping 33.33% to $2.60 on Thursday, after five sequential sessions in a row of losses. NASDAQ jumped 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Nova Lifestyle has a trailing twelve months EPS of $-8.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -128.88%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nova Lifestyle’s EBITDA is 0.46.
Moving Average
Nova Lifestyle’s worth is way higher than its 50-day moving average of $2.35 and below its 200-day moving average of $2.73.
More news about Nova Lifestyle.
3. NanoString Technologies (NSTG) – 9.35%
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq technologies. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
NASDAQ ended the session with NanoString Technologies jumping 9.35% to $0.55 on Thursday, after three sequential sessions in a row of losses. NASDAQ jumped 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, NanoString Technologies has a trailing twelve months EPS of $-3.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1028.56%.
Yearly Top and Bottom Value
NanoString Technologies’s stock is valued at $0.55 at 01:32 EST, way below its 52-week high of $13.20 and way above its 52-week low of $0.47.
Sales Growth
NanoString Technologies’s sales growth is 44.6% for the current quarter and 26.9% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
NanoString Technologies’s EBITDA is 1.21.
Volume
Today’s last reported volume for NanoString Technologies is 1730060 which is 9.11% below its average volume of 1903590.
More news about NanoString Technologies.
4. American Public Education (APEI) – 8.15%
American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 136 degree programs and 115 certificate programs in various fields of study, including nursing, public health, public administration, and business administration. It also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.
NASDAQ ended the session with American Public Education jumping 8.15% to $6.23 on Thursday, following the last session’s upward trend. NASDAQ rose 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, American Public Education has a trailing twelve months EPS of $-3.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.4%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.9%, now sitting on 600.18M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 137.1% and 92.1%, respectively.
Volatility
American Public Education’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.18%, a positive 1.05%, and a positive 3.44%.
American Public Education’s highest amplitude of average volatility was 3.18% (last week), 5.01% (last month), and 3.44% (last quarter).
Moving Average
American Public Education’s value is way above its 50-day moving average of $4.87 and higher than its 200-day moving average of $6.00.
More news about American Public Education.
5. MicroVision (MVIS) – 7.05%
MicroVision, Inc. develops and sells lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module supporting AR headsets; interactive display solutions for the smart speakers market; and Consumer Lidar used in smart home systems. In addition, it develops 1st Generation LRL module. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.
NASDAQ ended the session with MicroVision jumping 7.05% to $2.43 on Thursday, after two sequential sessions in a row of losses. NASDAQ jumped 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, MicroVision has a trailing twelve months EPS of $-0.43.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -83.29%.
Yearly Top and Bottom Value
MicroVision’s stock is valued at $2.43 at 01:32 EST, way below its 52-week high of $8.20 and way above its 52-week low of $1.82.
Sales Growth
MicroVision’s sales growth for the next quarter is 4800%.
Volatility
MicroVision’s last week, last month’s, and last quarter’s current intraday variation average was 0.59%, 0.91%, and 3.52%.
MicroVision’s highest amplitude of average volatility was 2.57% (last week), 4.30% (last month), and 3.52% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
MicroVision’s EBITDA is 184.05.
More news about MicroVision.
6. NeuroMetrix (NURO) – 6.83%
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix jumping 6.83% to $4.02 on Thursday, after two successive sessions in a row of losses. NASDAQ rose 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-5.6.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.61%.
Yearly Top and Bottom Value
NeuroMetrix’s stock is valued at $4.02 at 01:32 EST, way above its 52-week high of $2.18.
More news about NeuroMetrix.
7. Mercer International (MERC) – 6.82%
Mercer International Inc., together with its subsidiaries, manufactures and sells northern bleached softwood kraft (NBSK) pulp in Europe, the United States, Asia, and internationally. It operates through two segments, Pulp and Wood Products. The company also generates and sells green energy produced from biomass cogeneration power plant to third party utilities. In addition, it manufactures, distributes, and sells lumber and other wood residuals. Further, the company produces NBSK pulp primarily from wood chips, pulp logs, and sawlogs; carbon neutral or green energy using carbon-neutral bio-fuels, such as black liquor and wood waste; and tall oil for use as a chemical additive and green energy source. It sells its pulp to tissue, specialty paper, and printing and writing paper, and other manufacturers; and lumber products to distributors, construction firms, secondary manufacturers, retail yards, and home centers. The company was founded in 1968 and is headquartered in Vancouver, Canada.
NASDAQ ended the session with Mercer International jumping 6.82% to $10.03 on Thursday, after three sequential sessions in a row of gains. NASDAQ rose 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Mercer International has a trailing twelve months EPS of $-2.03.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.46%.
Moving Average
Mercer International’s value is way above its 50-day moving average of $8.68 and higher than its 200-day moving average of $9.16.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 18, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 2.99%.
Yearly Top and Bottom Value
Mercer International’s stock is valued at $10.03 at 01:32 EST, way below its 52-week high of $14.20 and way above its 52-week low of $7.37.
Revenue Growth
Year-on-year quarterly revenue growth declined by 11.6%, now sitting on 2.11B for the twelve trailing months.
More news about Mercer International.
8. AMC (AMC) – 6.69%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC rising 6.69% to $7.09 on Thursday while NYSE rose 0.28% to $15,905.48.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-3.
Previous days news about AMC
- AMC entertainment (amc) loses -21.83% in 4 weeks, here's why a trend reversal May be around the corner. According to Zacks on Tuesday, 21 November, "The heavy selling of AMC shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 29.9. ", "A downtrend has been apparent in AMC Entertainment (AMC Quick QuoteAMC – Free Report) lately with too much selling pressure. "
More news about AMC.
9. Baidu (BIDU) – 6.05%
Baidu, Inc. offers internet search services in China. It operates through Baidu Core and iQIYI segments. The company offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; Baidu Health that helps users to find the doctor and hospital for healthcare needs; and Haokan, a short video app. It also provides Baidu Knows, an online community where users can ask questions to other users; Baidu Wiki; Baidu Experience; Baidu Post; Baidu Wenku; Baidu Maps, a voice-enabled mobile app that provides travel-related services; Baidu Drive; Baijiahao; and DuerOS, a smart assistant platform. In addition, it offers online marketing services, which include pay for performance, an auction-based services that allow customers to bid for priority placement of paid sponsored links and reach users who search for information related to their products or services; other marketing services that include display-based marketing services and other online marketing services based on performance criteria other than cost per click; mobile ecosystem, a portfolio of apps, including Baidu App, Haokan, and Baidu Post; various cloud services and solutions, such as platform as a service, software as a service, and infrastructure as a service; self-driving services, including maps, automated valet parking, navigation pilot, electric vehicles, and robotaxi fleets, as well as Xiaodu smart devices. Further, the company provides iQIYI, an online entertainment service, including original and licensed content; other video content and membership; and online advertising services. Baidu, Inc. has strategic partnership with Zhejiang Geely Holding Group. The company was formerly known as Baidu.com, Inc. Baidu, Inc. was incorporated in 2000 and is headquartered in Beijing, China.
NASDAQ ended the session with Baidu jumping 6.05% to $120.28 on Thursday, after two successive sessions in a row of gains. NASDAQ jumped 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Baidu has a trailing twelve months EPS of $5.97.
PE Ratio
Baidu has a trailing twelve months price to earnings ratio of 20.15. Meaning, the purchaser of the share is investing $20.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.8%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Baidu’s EBITDA is 4.76.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Baidu’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.9%, now sitting on 130.82B for the twelve trailing months.
Volume
Today’s last reported volume for Baidu is 3766920 which is 68.76% above its average volume of 2232040.
Previous days news about Baidu
- Baidu (bidu) to post Q3 earnings: what's in the offing?. According to Zacks on Monday, 20 November, "Strength in Baidu’s mobile ecosystem is expected to have aided growth in the average daily active user base of the Baidu App in the quarter under review.BIDU’s well-performing iQIYI segment, offering online entertainment services, is expected to have bolstered the to-be-reported quarter’s performance.", "The company’s robust Baidu Cloud is anticipated to have benefited the business in the quarter under review."
More news about Baidu.
10. ImmunoGen (IMGN) – 5.65%
ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
NASDAQ ended the session with ImmunoGen jumping 5.65% to $16.07 on Thursday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, ImmunoGen has a trailing twelve months EPS of $-0.28.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.88%.
Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $16.07 at 01:32 EST, way under its 52-week high of $20.69 and way higher than its 52-week low of $3.61.
More news about ImmunoGen.
Losers Today
1. National American University Holdings (NAUH) – -14.47%
National American University Holdings, Inc. owns and operates National American University (NAU) that provides professional and technical postsecondary education primarily for working adults and other non-traditional students in the United States. It operates in two segments, NAU and Other. The company offers diploma, associate, baccalaureate, master's, and doctoral degree programs in business-related disciplines, such as accounting, management, business administration, and information technology; healthcare-related disciplines, including occupational therapy, medical assisting, nursing, surgical technology, and healthcare information and management; legal-related disciplines comprising paralegal, criminal justice, and professional legal studies; and higher education. As of July 31, 2019, it operated five 33 educational sites in Colorado, Indiana, Kansas, South Dakota, and Texas; and distance learning service centers and administration offices in Rapid City, South Dakota, as well as through the Internet. The company also engages in the real estate business, which rents apartment units; and develops and sells condominium units in the Fairway Hills Planned Residential Development area of Rapid City, South Dakota. National American University Holdings, Inc. was founded in 1941 and is headquartered in Rapid City, South Dakota.
NASDAQ ended the session with National American University Holdings sliding 14.47% to $0.02 on Thursday, after five sequential sessions in a row of losses. NASDAQ rose 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, National American University Holdings has a trailing twelve months EPS of $0.17.
PE Ratio
National American University Holdings has a trailing twelve months price to earnings ratio of 0.14. Meaning, the purchaser of the share is investing $0.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -183.64%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
National American University Holdings’s EBITDA is -11.47.
Volume
Today’s last reported volume for National American University Holdings is 1037 which is 27.83% below its average volume of 1437.
Moving Average
National American University Holdings’s worth is way below its 50-day moving average of $0.05 and way below its 200-day moving average of $0.07.
Yearly Top and Bottom Value
National American University Holdings’s stock is valued at $0.02 at 01:32 EST, under its 52-week low of $0.02.
More news about National American University Holdings.
2. Remark Holdings (MARK) – -13.93%
Remark Holdings, Inc. primarily focuses on the development and deployment of artificial-intelligence-based solutions for businesses and software developers. It owns and operates an e-commerce digital media property focuses on a luxury beach lifestyle. The company sells its AI-based products and services under the Remark AI brand in the United States; and under the KanKan brand in China. The company was incorporated in 2006 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Remark Holdings falling 13.93% to $0.49 on Thursday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Remark Holdings has a trailing twelve months EPS of $-2.63.
Yearly Top and Bottom Value
Remark Holdings’s stock is valued at $0.49 at 01:32 EST, way under its 52-week high of $2.80 and way above its 52-week low of $0.39.
More news about Remark Holdings.
3. Lightbridge Corporation (LTBR) – -10.49%
Lightbridge Corporation, together with its subsidiaries, develops nuclear fuel technology under the Lightbridge Fuel name. It focuses on developing and commercializing metallic nuclear fuels that could enhance resistance of nuclear fuel in existing and new nuclear reactors with a meaningful impact on addressing climate change and air pollution. The company was formerly known as Thorium Power, Ltd. and changed its name to Lightbridge Corporation in September 2009. Lightbridge Corporation was incorporated in 1992 and is based in Reston, Virginia.
NASDAQ ended the session with Lightbridge Corporation falling 10.49% to $3.50 on Thursday while NASDAQ rose 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Lightbridge Corporation has a trailing twelve months EPS of $-0.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.94%.
Volume
Today’s last reported volume for Lightbridge Corporation is 175666 which is 208.07% above its average volume of 57021.
More news about Lightbridge Corporation.
4. MediciNova (MNOV) – -9.71%
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has a collaboration agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.
NASDAQ ended the session with MediciNova dropping 9.71% to $1.86 on Thursday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, MediciNova has a trailing twelve months EPS of $-0.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.81%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MediciNova’s EBITDA is 40.39.
Yearly Top and Bottom Value
MediciNova’s stock is valued at $1.86 at 01:32 EST, way under its 52-week high of $2.73 and above its 52-week low of $1.71.
More news about MediciNova.
5. Nektar Therapeutics (NKTR) – -9.62%
Nektar Therapeutics operates as a biopharmaceutical company. The company researches and develops pipeline of investigational medicines in oncology, immunology, and virology, as well as a portfolio of approved partnered medicines. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of non-small cell lung cancer and immuno-oncology; and phase 1B clinical trial to treat COVID-19.It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat locally advanced or metastatic solid tumor malignancies, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.
NASDAQ ended the session with Nektar Therapeutics falling 9.62% to $0.47 on Thursday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Nektar Therapeutics has a trailing twelve months EPS of $-1.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.75%.
Sales Growth
Nektar Therapeutics’s sales growth for the current quarter is negative 15.5%.
Moving Average
Nektar Therapeutics’s worth is way below its 50-day moving average of $0.55 and way under its 200-day moving average of $0.84.
More news about Nektar Therapeutics.
6. LivePerson (LPSN) – -9.43%
LivePerson, Inc., together with its subsidiaries, provides conversational commerce solutions. The company operates in two segments, Business and Consumer. The Business segment enables brands to leverage LiveEngage's intelligence engine to connect with consumers through an integrated suite of mobile and online business messaging technologies. The Consumer segment facilitates online transactions between independent service providers and individual consumers seeking information and knowledge through mobile and online messaging. The company offers The Conversational Cloud, an enterprise-class and cloud-based platform, which enables businesses and consumers to connect through conversational interfaces, such as in-app and mobile messaging. It also provides professional services and value-added business consulting services. The company sells its products through direct and indirect sales channels to Fortune 500 companies, Internet businesses, online merchants, small businesses, automotive dealers, universities, libraries, government agencies, and not-for-profit organizations. It operates in the United States, Canada, Latin America, South America, Europe, the Middle East, Africa, and the Asia-Pacific region. The company has strategic partnerships with TTEC that focuses on customer experience; and DMI to redefine customer experience with digital engagement, messaging, and artificial intelligence driven automation. LivePerson, Inc. was founded in 1995 and is headquartered in New York, New York.
NASDAQ ended the session with LivePerson dropping 9.43% to $2.88 on Thursday, after two consecutive sessions in a row of losses. NASDAQ jumped 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, LivePerson has a trailing twelve months EPS of $-1.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.02%.
Yearly Top and Bottom Value
LivePerson’s stock is valued at $2.88 at 01:32 EST, way under its 52-week high of $18.17 and way higher than its 52-week low of $2.33.
Moving Average
LivePerson’s value is way under its 50-day moving average of $3.27 and way under its 200-day moving average of $5.11.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 41.8% and a drop 17.4% for the next.
More news about LivePerson.
7. Neptune Wellness Solutions (NEPT) – -9.41%
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
NASDAQ ended the session with Neptune Wellness Solutions sliding 9.41% to $0.77 on Thursday, following the last session’s downward trend. NASDAQ rose 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Neptune Wellness Solutions has a trailing twelve months EPS of $-44.13.
Moving Average
Neptune Wellness Solutions’s worth is way under its 50-day moving average of $1.50 and way below its 200-day moving average of $10.58.
Volume
Today’s last reported volume for Neptune Wellness Solutions is 508422 which is 34.39% below its average volume of 775006.
Yearly Top and Bottom Value
Neptune Wellness Solutions’s stock is valued at $0.77 at 01:32 EST, way below its 52-week high of $41.60 and way above its 52-week low of $0.62.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Neptune Wellness Solutions’s EBITDA is 0.59.
More news about Neptune Wellness Solutions.
8. Liberty Global plc (LBTYB) – -7.9%
Liberty Global plc, together with its subsidiaries, provides broadband internet, video, fixed-line telephony, and mobile communications services to residential customers and businesses. It offers value-added broadband services, such as intelligent WiFi features; security; smart home, online storage solutions, and Web spaces; and Connect Box, a connectivity device that delivers in-home Wi-Fi coverage. The company also provides community Wi-Fi via routers in home, which provides access to the Internet; public Wi-Fi access points in train stations, hotels, bars, restaurants, and other public places. In addition, its cable operations comprise various tiers of digital video programming and audio services, as well as offers digital video recorders and multimedia home gateway systems. The company's channel offerings include general entertainment, sports, movies, documentaries, lifestyles, news, adult, children, and ethnic and foreign channels. Further, it provides mobile services, such as voice, short message service, and Internet access; circuit-switched telephony services; and personal call manager, unified messaging, and a second or third phone line at an incremental cost. Additionally, the company offers voice, advanced data, video, wireless, cloud-based services, and mobile and converged fixed-mobile services to small business and medium and large enterprises, as well as on a wholesale basis to other operators. It serves in the United Kingdom, Belgium, Switzerland, Ireland, Poland, Slovakia, and internationally. Liberty Global plc was founded in 2004 and is based in London, the United Kingdom.
NASDAQ ended the session with Liberty Global plc sliding 7.9% to $15.74 on Thursday while NASDAQ jumped 0.46% to $14,265.86.
Earnings Per Share
As for profitability, Liberty Global plc has a trailing twelve months EPS of $-10.66.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.94%.
Volatility
Liberty Global plc’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.72%, a negative 0.36%, and a positive 2.82%.
Liberty Global plc’s highest amplitude of average volatility was 1.88% (last week), 3.67% (last month), and 2.82% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 7.41B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Liberty Global plc’s EBITDA is 2.72.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Liberty Global plc’s stock is considered to be oversold (<=20).
More news about Liberty Global plc.
9. Virgin Galactic (SPCE) – -7.75%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.
NYSE ended the session with Virgin Galactic sliding 7.75% to $1.97 on Thursday, following the last session’s downward trend. NYSE rose 0.28% to $15,905.48, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-1.81.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -90.56%.
Volatility
Virgin Galactic’s last week, last month’s, and last quarter’s current intraday variation average was 0.91%, 1.62%, and 4.95%.
Virgin Galactic’s highest amplitude of average volatility was 4.44% (last week), 6.60% (last month), and 4.95% (last quarter).
Previous days news about Virgin Galactic
- : Virgin Galactic stock on pace to snap two-day winning streak. According to MarketWatch on Tuesday, 21 November, "Shares of Virgin Galactic Holdings Inc. SPCE are down 5.1% Tuesday, putting the stock on pace to snap a two-day winning streak. "
More news about Virgin Galactic.
10. Lipocine (LPCN) – -6.69%
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase II Clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH); TLANDO XR, an oral prodrug of testosterone for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, an oral prodrug of bioidentical testosterone that has completed phase I clinical trial for the treatment of NASH cirrhosis; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.
NASDAQ ended the session with Lipocine sliding 6.69% to $2.51 on Thursday, following the last session’s upward trend. NASDAQ jumped 0.46% to $14,265.86, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Lipocine has a trailing twelve months EPS of $-3.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.22%.
Moving Average
Lipocine’s value is way below its 50-day moving average of $2.83 and way under its 200-day moving average of $4.64.
Yearly Top and Bottom Value
Lipocine’s stock is valued at $2.51 at 01:32 EST, way below its 52-week high of $10.34 and above its 52-week low of $2.31.
Volume
Today’s last reported volume for Lipocine is 7580 which is 64.91% below its average volume of 21603.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Lipocine’s EBITDA is 8.86.
More news about Lipocine.
Stay up to date with our winners and losers daily report
